Genetic Roadmap Boosts Precision Therapy for ICC
Intrahepatic cholangiocarcinoma (iCCA), the second most common liver cancer after hepatocellular carcinoma, remains one of the most difficult diseases to treat due to its highly hidden and heterogeneous nature. A collaborative team from BGI Genomics and Fudan University’s Zhongshan Hospital has now mapped the molecular “chaos” of iCCA, providing a roadmap for more accurate diagnosis … Read more
